Literature DB >> 22012172

A case of posterior reversible encephalopathy syndrome after emergence from anesthesia.

Satoki Inoue1, Masahiko Kawaguchi, Hitoshi Furuya.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a relatively new clinical entity characterized by reversible neurological symptoms with findings indicating leukoencephalopathy on imaging studies. Reports of PRES in the field of anesthesiology have been quite limited. A patient with therapeutic anticoagulant developed PRES immediately after emergence from anesthesia, in which her status was initially recognized as delayed recovery from anesthesia with transient hypertension because an emergent head computed tomography (CT) scan was almost normal. Subsequently, magnetic resonance imaging (MRI) was also performed according to a radiologist's recommendation because the CT results showed areas of slightly low attenuation in the frontoparieto-occipital lobes bilaterally, suggesting PRES; otherwise, ischemic events. MRI showed subcortical increased T(2) and fluid-attenuated inversion recovery (FLAIR) intensity in the occipitoparietal regions bilaterally with slight increase in the apparent diffusion coefficient signal on diffusion-weighted imaging, which confirmed a diagnosis of PRES. Gradually, the patient regained consciousness and became responsive with antihypertensive therapy. A prompt and accurate diagnosis of PRES is important to avoid irreversible brain damage, for example, intracranial hemorrhage, especially in a patient receiving anticoagulation therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22012172     DOI: 10.1007/s00540-011-1256-7

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  3 in total

1.  The effects of fentanyl and sufentanil on cerebral hemodynamics.

Authors:  F Hänel; C Werner; G von Knobelsdorff; J Schulte am Esch
Journal:  J Neurosurg Anesthesiol       Date:  1997-07       Impact factor: 3.956

2.  Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans.

Authors:  Jaakko W Långsjö; Kaike K Kaisti; Sargo Aalto; Susanna Hinkka; Riku Aantaa; Vesa Oikonen; Hannu Sipilä; Timo Kurki; Martti Silvanto; Harry Scheinin
Journal:  Anesthesiology       Date:  2003-09       Impact factor: 7.892

3.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

  3 in total
  5 in total

1.  Malignant Posterior Reversible Encephalopathy Syndrome-An Exacting Challenge for Neurocritical Care Physicians.

Authors:  Shahvaiz Magsi; Atif Zafar
Journal:  Neurohospitalist       Date:  2017-02-08

2.  An unusual case of posterior reversible encephalopathy syndrome in a patient being weaned from intrathecal morphine.

Authors:  Jasper Van Aalst; Onno P Teernstra; Wim E Weber; Kim Rijkers
Journal:  Int Med Case Rep J       Date:  2016-05-17

3.  Perioperative posterior reversible encephalopathy syndrome in a patient with no history of hypertension: a case report.

Authors:  Nobuo Sato; Haruhiko Machida; Mitsuharu Kodaka; Keiko Nishiyama; Makiko Komori
Journal:  JA Clin Rep       Date:  2016-11-21

4.  A case of posterior reversible encephalopathy syndrome during endoscopic retrograde cholangiopancreatography after anesthesia.

Authors:  Amir Sadeghi; Isa Bakhshandeh Moghadam; Azita Hekmatdoost; Niloufar Salehi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2022

5.  Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy.

Authors:  Jordi Gandini; Mario Manto; Nicolas Charette
Journal:  Front Neurol       Date:  2020-01-30       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.